Takara Bio Stock

Takara Bio ROCE 2024

Takara Bio ROCE

0.03

Ticker

4974.T

ISIN

JP3460200003

WKN

A0DNGL

In 2024, Takara Bio's return on capital employed (ROCE) was 0.03, a -91.07% increase from the 0.3 ROCE in the previous year.

Takara Bio Aktienanalyse

What does Takara Bio do?

Takara Bio Inc is a Japanese biotechnology company that has been active in the medical and life science industry since its founding in 1967. The company is a strong player in the field of molecular biology and operates in several countries such as the USA, Europe, and Asia. Takara Bio Inc was established as an independent company in 1999, focusing exclusively on the production of molecular biology products. The company offers a wide range of products in the fields of research and diagnostics, including enzymes, PCR kits, vectors and plasmids, antibodies, proteins, and cell culture products. Takara Bio Inc is organized into two divisions: Life Science Research and Diagnostics. The Life Science Research division provides products and solutions for research and development in areas such as molecular biology, neuroscience, proteomics, and genomics. The Diagnostics division offers products and solutions for clinical diagnostics and drug development. Takara Bio Inc also specializes in the automation of molecular biology procedures and offers automated systems that can perform processes such as nucleic acid extraction, PCR, and sequencing. The company is committed to sustainability and environmental protection, adhering to strict environmental and quality standards in its production processes and implementing waste reduction and efficient resource utilization programs. Overall, Takara Bio Inc is a leading company in the field of molecular biology, offering a wide range of products and solutions for research and diagnostics, and has become a key player in the life science industry through its global expansion and ability to provide custom solutions. Takara Bio ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Takara Bio's Return on Capital Employed (ROCE)

Takara Bio's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Takara Bio's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Takara Bio's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Takara Bio’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Takara Bio stock

What is the ROCE (Return on Capital Employed) of Takara Bio this year?

The ROCE of Takara Bio is 0.03 undefined this year.

How has the ROCE (Return on Capital Employed) of Takara Bio developed compared to the previous year?

The ROCE of Takara Bio has increased by -91.07% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Takara Bio?

A high Return on Capital Employed (ROCE) indicates that Takara Bio has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Takara Bio?

A low ROCE (Return on Capital Employed) can indicate that Takara Bio has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Takara Bio impact the company?

An increase in the ROCE of Takara Bio can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Takara Bio affect the company?

A decrease in ROCE of Takara Bio can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Takara Bio?

Some factors that can affect Takara Bio's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Takara Bio so important for investors?

The ROCE of Takara Bio is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Takara Bio take to improve the ROCE?

To improve the ROCE, Takara Bio can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Takara Bio pay?

Over the past 12 months, Takara Bio paid a dividend of 17 JPY . This corresponds to a dividend yield of about 1.64 %. For the coming 12 months, Takara Bio is expected to pay a dividend of 19.79 JPY.

What is the dividend yield of Takara Bio?

The current dividend yield of Takara Bio is 1.64 %.

When does Takara Bio pay dividends?

Takara Bio pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Takara Bio?

Takara Bio paid dividends every year for the past 16 years.

What is the dividend of Takara Bio?

For the upcoming 12 months, dividends amounting to 19.79 JPY are expected. This corresponds to a dividend yield of 1.9 %.

In which sector is Takara Bio located?

Takara Bio is assigned to the 'Health' sector.

Wann musste ich die Aktien von Takara Bio kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Takara Bio from 6/1/2024 amounting to 17 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Takara Bio pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Takara Bio in the year 2023?

In the year 2023, Takara Bio distributed 42 JPY as dividends.

In which currency does Takara Bio pay out the dividend?

The dividends of Takara Bio are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Takara Bio

Our stock analysis for Takara Bio Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Takara Bio Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.